HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Ungar Selected Research

Pain (Aches)

12/2021Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Ungar Research Topics

Disease

4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 12/2019
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Pain (Aches)
12/2021
1Nausea
01/2021
1Fatigue
01/2021
1Neutropenia
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Edema (Dropsy)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020
1Neoplasms (Cancer)
11/2020
1Lymphoma (Lymphomas)
05/2008
1X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation
05/2008

Drug/Important Bio-Agent (IBA)

7loncastuximab tesirineIBA
01/2022 - 12/2019
3Immunoconjugates (Immunoconjugate)IBA
01/2021 - 12/2019
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
12/2021 - 01/2021
1EnzymesIBA
01/2021
1AntigensIBA
11/2020
1pyrrolo(2,1-c)(1,4)benzodiazepineIBA
12/2019
1Sirolimus (Rapamycin)FDA Link
05/2008

Therapy/Procedure

2Salvage Therapy
01/2021 - 01/2021
1Therapeutics
01/2022